Leonteq Securities’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
Other funds holding TGTX
Leonteq Securities's TGTX Position: Q3 2026 in Review
Leonteq Securities opened a new position in TG Therapeutics (TGTX) in Q3 2026: 525 shares worth $29.3K. The stake represents ﹤0.01% of the portfolio and ranks #868 among its holdings. This is a return to the name: Leonteq Securities previously reported a position in TGTX as recently as Q4 2025.
Leonteq Securities first reported a position in TGTX in Q1 2021 and has held it in 15 quarters since. The position peaked at $119K in Q4 2025. 370 funds tracked by Wall St. Rank hold TGTX as of Q3 2026.
- Leonteq Securities held 525 shares of TG Therapeutics worth $29.3K as of Q3 2026.
- TG Therapeutics was a new Leonteq Securities position in Q3 2026.
- TG Therapeutics made up ﹤0.01% of Leonteq Securities's portfolio in Q3 2026, its #868 holding.
- Leonteq Securities first reported a position in TG Therapeutics in Q1 2021 and has held it in 15 quarters since.
- Leonteq Securities's TG Therapeutics position peaked at $119K in Q4 2025.
- 370 funds tracked by Wall St. Rank held TG Therapeutics as of Q3 2026.
Based on Leonteq Securities's 13F filing for Q3 2026, filed 29 Oct 2026.